Key result
Minimally invasive AVR via J-sternotomy demonstrates feasibility for reoperation with ~5% hospital mortality.
Why the study?
Is minimally invasive aortic valve replacement via J-sternotomy feasible and safe as a reoperative cardiac procedure?
Population
19 consecutive patients undergoing aortic valve replacement via J-sternotomy as a reoperative cardiac…
Design
Case_series
Follow-up
Mean 23.6 +/- 19.7 months
Authors
Loading...
May support J-sternotomy reoperative AVR in select cases; leaves open need for comparative prospective data before wider adoption.
Observational (n=19)
Is minimally invasive aortic valve replacement via J-sternotomy feasible and safe as a reoperative cardiac procedure?
Minimally invasive aortic valve replacement via J-sternotomy is feasible as a reoperative procedure, offering the advantage of avoiding full cardiac reexposure.
Bakır et al. (2007) conducted an observational in Aortic valve disease requiring reoperative cardiac surgery (n=19). Minimally invasive aortic valve replacement via J-sternotomy was evaluated on Hospital death. Minimally invasive aortic valve replacement via J-sternotomy was feasible as a reoperative procedure, with 100% procedural success and a 5% hospital mortality rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: